- Filed
- Apr 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 31, 2025 | 8.14M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 7.95M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2023 | $0 |
| Capex | FY 2024 · Dec 31, 2023 | $0 |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | $235.52K |
| Cash And Equivalents restated | FY 2024 · Dec 31, 2023 | $1.73M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $1.93M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $2.83M |
| Current Assets restated | FY 2024 · Dec 31, 2023 | $4.53M |
| Total Assets restated | FY 2024 · Dec 31, 2023 | $6.97M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | $0.04 |
| Eps Basic | FY 2024 · Dec 31, 2023 | $0.04 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $1.39M |
| Net Income | FY 2024 · Dec 31, 2023 | $353.21K |
| Operating Income | FY 2024 · Dec 31, 2023 | −$587.82K |
| Gross Profit | FY 2024 · Dec 31, 2023 | $3.79M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $12.78M |
| Revenue | FY 2024 · Dec 31, 2023 | $16.56M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2022 | $3.05M |